AGY Therapeutics
A South San Francisco, Calif -based biopharmaceutical company.
Launch date
Employees
Market cap
-
Enterprise valuation
€33—49m (Dealroom.co estimates Aug 2004.)
South San Francisco California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$13.0m | Series B | ||
$9.0m | Series C | ||
| Total Funding | €20.0m | ||